focus -WSS

focus

author：explore 2025-09-01 15:18:00 - browse：896

Biogen announced a new round of cost cuts Tuesday, saying that it plans to save $700 million in operating costs and cut 1,000 jobs by 2025.

The company also released second quarter sales and earnings that handily topped the forecasts of Wall Street analysts. In early morning trading, Biogen shares rose more than 1%.

Biogen is attempting to recover from a series of corporate stumbles, the biggest of which involved the development and launch of the Alzheimer’s drug Aduhelm. The medicine was the first of a new class of disease-modifying Alzheimer’s drugs to be approved by the Food and Drug Administration. But doubts about the quality of the data behind the medicine meant that Medicare wouldn’t pay for it and doctors did not prescribe it. The resulting financial disaster cleaned out Biogen’s executive suite.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Deliver public health messages at the right time

WSS

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

UPS workers' union leader explains what's at stake as strike edges closer

How redistricting in 6 states could affect who controls Congress

PBM executives asked to testify by House panel

Crowdfunding for medical bills sidesteps core problem, author says

US intelligence assessment says Iran not currently developing nuclear weapons

focus

focus

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

As health system earnings go up, health insurance stocks go down

Activists slam private health insurers over coverage restrictions

How redistricting in 6 states could affect who controls Congress

Cancer drug shortages should be causing more outrage

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

Alkermes shareholders re

Warren pushes Witty on UnitedHealth's control over physicians

In Memoriam: Notable people who died in 2023

What could happen if Russia blows up the Zaporizhzhia Nuclear Power Plant?

focus

House panel to mark up pandemic

HHS's proposed rule does nothing to address the climate crisis

Novel spinal cord stimulator treats paralysis without surgery

With fresh data, a dynamic duo powers Eli Lilly to new heights

Crowdfunding for medical bills sidesteps core problem, author says

House panel to mark up pandemic

leisure time

hotspot

hotspot

focus